Lipid Keratopathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Lipid Keratopathy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT00681603

Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization

1. Purpose:Our animal study demonstrated the effectiveness of subconjunctival injection of bevacizumab in the inhibition of corneal neovasculization formation.…

Taiwan13 participantsStarted 2007-08

Treatment: subconjunctival injection of bevacizumab ( 1.25 to 2.50 mg)